Cancer Research CR Mantle  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 6140-6145, December 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zambello, R.
Right arrow Articles by Semenzato, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zambello, R.
Right arrow Articles by Semenzato, G.

Analysis of the T Cell Receptor in the Lymphoproliferative Disease of Granular Lymphocytes: Superantigen Activation of Clonal CD3+ Granular Lymphocytes1

Renato Zambello, Livio Trentin, Monica Facco, Andrea Cerutti, Rosaria Sancetta, Antonella Milani, Roberto Raimondi, Cristina Tassinari, Carlo Agostini and Gianpietro Semenzato2

Department of Clinical and Experimental Medicine, Padua University School of Medicine, Clinica Medica 1, Via Giustiniani 2, 35128 Padua [R. Z., L. T., M. F., A. C., R. S., A. M., C. T., C. A., G. S.], and Division of Hematology, Vicenza Hospital, 36100 Vicenza [R. Z. L. T., R. R.], Italy

To investigate whether cell populations in CD3+ lymphoproliferative disease of granular lymphocytes (LDGLs) were skewed toward the use of specific Vß regions, we studied the repertoire of T-cell receptor (TCR) Vß gene products in 18 patients, as well as their relationship to the clonal bands in the Southern blot and the activation mediated by superantigens.

Using a panel of monoclonal antibodies (mAbs) for conserved Vß segments and PCR, a dominant population expressing a specific Vß region was demonstrated in all patients. In five (27%) cases, granular lymphocytes (GLs) were found to express the Vß 13.1, while Vß8 and Vß6 were each expressed in three (17%) cases. The remaining cases were characterized by the proliferation of TCR Vß2, Vß3, Vß4, Vß9, Vß12, Vß16, and Vß20. This finding indicates a biased usage of a limited TCR Vß in LDGLs, since nearly 60% of the cases utilized only three families of the TCR Vß genes. In all of the cases studied, we proved that the subset recognized by mAb and PCR was identical to that accounting for the extra band(s) of the Southern blot. This finding confirms the clonal nature of the population identified according to TCR Vß expression both by phenotype and PCR. On functional grounds, we evaluated whether GLs can be activated through the specific TCR using the superantigens recognizing discrete Vß families, such as staphylococcal proteins, including SEA, SEB, SEC1, SEC2, SED, and SEE. We demonstrated that the TCR-{alpha} of clonal GLs in LDGL patients is functionally active in delivering cytotoxic and proliferative signals upon superantigen activation.

1 This work was supported in part by Consiglio Nazionale delle Ricerche, Rome (Clinical Application of Oncological Research) and Associazione Italiana per la Ricerca sul Cancro, Milan.

2 To whom requests for reprints should be addressed, at Istituto di Medicina Clinica dell' Università di Padova, Clinica Medica 1, Via Giustiniani 2, 35128 Padua, Italy. Phone: 011-39-49-8212298; Fax: 011-39-49-8754179.

Received 7/20/95. Accepted 10/16/95.




This article has been cited by other articles:


Home page
haematolHome page
R. Zambello and G. Semenzato
Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches
Haematologica, October 1, 2009; 94(10): 1341 - 1345.
[Full Text] [PDF]


Home page
The OncologistHome page
L. Sokol and T. P. Loughran Jr.
Large granular lymphocyte leukemia.
Oncologist, March 1, 2006; 11(3): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zambello, T. Berno, G. Cannas, I. Baesso, G. Binotto, E. Bonoldi, P. Bevilacqua, M. Miorin, M. Facco, L. Trentin, et al.
Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL)
Blood, December 1, 2005; 106(12): 3926 - 3931.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Lima, J. Almeida, A. H. Santos, M. dos Anjos Teixeira, M. del Carmen Alguero, M. L. Queiros, A. Balanzategui, B. Justica, M. Gonzalez, J. F. San Miguel, et al.
Immunophenotypic Analysis of the TCR-V{beta} Repertoire in 98 Persistent Expansions of CD3+/TCR-{alpha}{beta}+ Large Granular Lymphocytes : Utility in Assessing Clonality and Insights into the Pathogenesis of the Disease
Am. J. Pathol., November 1, 2001; 159(5): 1861 - 1868.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr.
T Cell and NK Cell Lymphoproliferative Disorders
Hematology, January 1, 2001; 2001(1): 259 - 281.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zambello, L. Trentin, M. Facco, M. Siviero, S. Galvan, F. Piazza, A. Perin, C. Agostini, and G. Semenzato
Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes
Blood, July 15, 2000; 96(2): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. H. Liu, S. Wei, T. Lamy, P. K. Epling-Burnette, G. Starkebaum, J. Y. Djeu, and T. P. Loughran Jr
Chronic neutropenia mediated by Fas ligand
Blood, May 15, 2000; 95(10): 3219 - 3222.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Lamy, J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr
Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia
Blood, December 15, 1998; 92(12): 4771 - 4777.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zambello, M. Facco, L. Trentin, R. Sancetta, C. Tassinari, A. Perin, A. Milani, G. Pizzolo, F. Rodeghiero, C. Agostini, et al.
Interleukin-15 Triggers the Proliferation and Cytotoxicity of Granular Lymphocytes in Patients With Lymphoproliferative Disease of Granular Lymphocytes
Blood, January 1, 1997; 89(1): 201 - 211.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Semenzato, R. Zambello, G. Starkebaum, K. Oshimi, and T. P. Loughran Jr
The Lymphoproliferative Disease of Granular Lymphocytes: Updated Criteria for Diagnosis
Blood, January 1, 1997; 89(1): 256 - 260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.